BCRX BIOCRYST PHARMACEUTICALS INC: institutional ownership and insider trading
329 funds reported holding $2.94B of BIOCRYST PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net bought $123M, with 52 new positions and 38 funds selling out; over the last 12 months insiders bought $0 and sold $4.14M on the open market; over its last four quarters it reported revenue of $941M and net income of −$385M.
BCRX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $218M, net income $78.4M, EPS 0.30
- Quarter ended Mar 31, 2026: revenue $156M, net income −$722M, EPS -2.98
- Quarter ended Dec 31, 2025: revenue $407M, net income $246M, EPS 1.13
- Quarter ended Sep 30, 2025: revenue $159M, net income $12.9M, EPS 0.06
Famous investors holding BCRX
- Two Sigma (Two Sigma Investments): $67.8M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $25.3M, 0.0% of the portfolio
- Ray Dalio (Bridgewater Associates): $4.91M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $33.9M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $21.4M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $4.09M, 0.0% of the portfolio
Largest institutional holders of BCRX
- BlackRock, Inc. (BLK) — $239M
- VANGUARD GROUP INC — $174M
- RA CAPITAL MANAGEMENT, L.P. — $158M
- STATE STREET CORP (STT, STT-PG) — $152M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $151M
- VANGUARD CAPITAL MANAGEMENT LLC — $114M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $111M
- TCG Crossover Management, LLC — $110M
- PERCEPTIVE ADVISORS LLC — $103M
- Jupiter Topco LLC — $95.3M
Recent BCRX insider trades
- May 18, 2026: McKee Amy E sold 11,180 shares ($100K)
- May 13, 2026: Barnes Alane P sold 62,500 shares ($596K)
- Mar 20, 2026: Heggie Theresa sold 49,933 shares ($505K)
- Mar 16, 2026: Barnes Alane P sold 150,000 shares ($1.37M)
Members of Congress trading BCRX
- Jul 10, 2026: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Nov 13, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
5%+ owners
- RA Capital Management, L.P.: 6.2% (Schedule 13G/A, filed Aug 14, 2026)
- STATE STREET CORPORATION: 6.0% (Schedule 13G, filed Aug 7, 2026)
- Vanguard Capital Management: 5.2% (Schedule 13G, filed Apr 29, 2026)